Skip to main content

BioRestorative Therapies, Inc.

BRTX
Exchange
Nasdaq
Industry
Services-Misc Health & Allied Services, NEC
SEC CIK
0001505497

No open-market purchases or sales by BioRestorative Therapies, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $1.00M in total; no superinvestor holds it.

Holders of 5% or more of BRTX

Holders whose latest Schedule 13D or 13G filing reports 5% or more of BioRestorative Therapies, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of BRTX
HolderLatest formStakeChangeFirst filedLatest filingFiling
Alstodt Lance13D/A15.50%1.24M shares–Mar 19, 20214 filingsFeb 19, 2025SEC
Silva Francisco13D/A15.10%1.20M shares–Mar 19, 20214 filingsFeb 19, 2025SEC
Auctus Fund Management LLC13G/A9.90%2.70M shares0.00 ppfrom 9.90%Jul 14, 20228 filingsMay 15, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

36 Schedule 13D and 13G filings on BioRestorative Therapies, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on BRTX
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 3, 20264:17 PM ETAlta Partners LLC13G/A4.90%1.34M shares−2.80 ppfrom 7.70%Below 5%Feb 13, 2026SEC
May 15, 20263:30 PM ETAuctus Fund Management LLCand 3 others13G/A9.90%2.70M shares0.00 ppfrom 9.90%Mar 31, 2026SEC
Feb 23, 20264:50 PM ETMorrison Todd Hale13G/A0.00%0 shares−7.70 ppfrom 7.70%Below 5%Feb 23, 2026SEC
Feb 18, 20264:12 PM ETIntracoastal Capital, LLCand 2 others13G4.10%922.1K sharesNewBelow 5%Feb 11, 2026SEC
Feb 17, 20262:16 PM ETAuctus Fund Management LLCand 3 others13G/A9.90%895.9K shares0.00 ppfrom 9.90%Dec 31, 2025SEC
Feb 13, 20264:20 PM ETAlta Partners LLC13G7.70%1.79M sharesNewFeb 13, 2026SEC
Dec 19, 20253:06 PM ETMorrison Todd Hale13G/A7.70%685.0K shares–Dec 18, 2025SEC
Aug 14, 20253:12 PM ETAuctus Fund Management LLCand 3 others13G/A9.90%784.7K shares0.00 ppfrom 9.90%Jun 30, 2025SEC
May 15, 202511:32 AM ETAuctus Fund Management LLCand 3 others13G/A9.90%759.1K shares0.00 ppfrom 9.90%Mar 31, 2025SEC
Feb 28, 20257:57 AM ETMorrison Todd Hale13G/A––Feb 27, 2025SEC
Feb 19, 20254:43 PM ETSilva Francisco13D/A15.10%1.20M shares–Feb 14, 2025SEC
Feb 19, 20254:39 PM ETAlstodt Lance13D/A15.50%1.24M shares–Feb 14, 2025SEC
Feb 19, 20257:54 AM ETMorrison Todd Hale13G/A––Feb 18, 2025SEC
Feb 10, 20254:29 PM ETMorrison Todd Hale13G/A––Feb 10, 2025SEC
Dec 5, 20245:37 PM ETMorrison Todd Hale13G/A––Jun 12, 2024SEC
Nov 14, 202412:33 PM ETAuctus Fund Management LLCand 3 others13G/A9.90%692.4K shares–Sep 30, 2024SEC
Jun 21, 20246:33 PM ETMorrison Todd Hale13G8.10%550.0K sharesNewJun 12, 2024SEC
Mar 6, 2024Broadrick Dale13D/AOld format–––SEC
Feb 15, 2024Silva Francisco13D/AOld format–––SEC
Feb 15, 2024Alstodt Lance13D/AOld format–––SEC
Feb 14, 2024Auctus Fund Management LLC13G/AOld format–––SEC
Feb 17, 2023Silva Francisco13D/AOld format–––SEC
Feb 17, 2023Alstodt Lance13D/AOld format–––SEC
Feb 14, 2023Auctus Fund Management LLC13G/AOld format–––SEC
Feb 7, 2023Hudson Bay Capital Management LP13G/AOld format–––SEC
Jul 14, 2022Auctus Fund Management LLC13GOld format–New–SEC
Jun 21, 2022Broadrick Dale13D/AOld format–––SEC
Apr 7, 2022Broadrick Dale13D/AOld format–––SEC
Mar 29, 2022Broadrick Dale13D/AOld format–––SEC
Feb 14, 2022Altium Capital Management LP13G/AOld format–––SEC
Feb 2, 2022Hudson Bay Capital Management LP13GOld format–New–SEC
Jan 4, 2022Sabby Management, LLC13G/AOld format–––SEC
Nov 16, 2021Altium Capital Management LP13GOld format–New–SEC
Nov 9, 2021Sabby Management, LLC13GOld format–New–SEC
Mar 19, 2021Silva Francisco13DOld format–New–SEC
Mar 19, 2021Alstodt Lance13DOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell BioRestorative Therapies, Inc. shares.

No Form 144 notices for BioRestorative Therapies, Inc. are on file.